Will stem cell biology generate new therapies for Parkinson's disease?
Three papers recently published in Nature Medicine provide the most detailed analyses of fetal midbrain grafts in patients with Parkinson's disease. Some of the results are surprising and suggest a new wave of questions aimed at both the value of cell therapy and the nature of the disease itself.
Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. ronmckay@mail.nih.gov
Ron
R
McKay
Raja
R
Kittappa
D016380:Brain Tissue Transplantation / Q000379:methods*; D005333:Fetus; D006801:Humans; D010300:Parkinson Disease / Q000628:therapy*; D013234:Stem Cells / Q000502:physiology*